[go: up one dir, main page]

SK102199A3 - Peptides comprising a t-cell epitope specific to collagen ii, their use and pharmaceutical compositions containing such peptides - Google Patents

Peptides comprising a t-cell epitope specific to collagen ii, their use and pharmaceutical compositions containing such peptides Download PDF

Info

Publication number
SK102199A3
SK102199A3 SK1021-99A SK102199A SK102199A3 SK 102199 A3 SK102199 A3 SK 102199A3 SK 102199 A SK102199 A SK 102199A SK 102199 A3 SK102199 A3 SK 102199A3
Authority
SK
Slovakia
Prior art keywords
apg
amino acid
ppg
peptide
pag
Prior art date
Application number
SK1021-99A
Other languages
English (en)
Slovak (sk)
Inventor
Sinasi Bayrak
Rikard Holmdahl
Avrion Mitchison
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK102199A3 publication Critical patent/SK102199A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK1021-99A 1997-01-31 1998-01-29 Peptides comprising a t-cell epitope specific to collagen ii, their use and pharmaceutical compositions containing such peptides SK102199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700301A SE9700301D0 (sv) 1997-01-31 1997-01-31 New compound
PCT/SE1998/000128 WO1998033811A1 (fr) 1997-01-31 1998-01-29 Peptides contenant un epitope de lymphocyte t specifique au collagene ii

Publications (1)

Publication Number Publication Date
SK102199A3 true SK102199A3 (en) 2000-08-14

Family

ID=20405590

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1021-99A SK102199A3 (en) 1997-01-31 1998-01-29 Peptides comprising a t-cell epitope specific to collagen ii, their use and pharmaceutical compositions containing such peptides

Country Status (19)

Country Link
EP (1) EP1007547A1 (fr)
JP (1) JP2001511143A (fr)
KR (1) KR20000070542A (fr)
CN (1) CN1246125A (fr)
AU (1) AU744907B2 (fr)
BR (1) BR9811250A (fr)
CA (1) CA2278638A1 (fr)
EE (1) EE9900334A (fr)
HU (1) HUP0000836A3 (fr)
ID (1) ID22802A (fr)
IL (1) IL131045A0 (fr)
IS (1) IS5138A (fr)
NO (1) NO993684L (fr)
NZ (1) NZ336745A (fr)
PL (1) PL334877A1 (fr)
SE (1) SE9700301D0 (fr)
SK (1) SK102199A3 (fr)
TR (1) TR199901831T2 (fr)
WO (1) WO1998033811A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO571297A0 (en) * 1997-03-19 1997-04-10 Montech Medical Developments Pty Ltd Method for the diagnosis of rheumatoid arthritis
EP1420806B1 (fr) * 2001-07-12 2013-05-01 Rikard Holmdahl Méthode de détection d'anticorps au moyen de complexes triples de polypeptides dérivés du collagène ii
PL369029A1 (en) * 2001-09-14 2005-04-18 Biora Bioex Ab Enamel matrix protein compositions for modulating immune response
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
WO2008130217A1 (fr) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Analogues d'angiotensines cycliques
KR20170002734U (ko) 2016-01-21 2017-07-31 김인수 자동 목재절단 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08151396A (ja) * 1994-11-28 1996-06-11 Teijin Ltd Ｈｌａ結合性オリゴペプチド及びそれを含有する免疫調節剤
AU4695296A (en) * 1995-01-06 1996-07-24 Immulogic Pharmaceutical Corporation Compositions and methods for treating rheumatoid arthritis

Also Published As

Publication number Publication date
HUP0000836A2 (hu) 2000-11-28
EP1007547A1 (fr) 2000-06-14
NO993684L (no) 1999-09-02
SE9700301D0 (sv) 1997-01-31
TR199901831T2 (xx) 1999-10-21
IL131045A0 (en) 2001-01-28
BR9811250A (pt) 2000-09-26
EE9900334A (et) 2000-02-15
CN1246125A (zh) 2000-03-01
HUP0000836A3 (en) 2001-04-28
CA2278638A1 (fr) 1998-08-06
ID22802A (id) 1999-12-09
IS5138A (is) 1999-07-28
NZ336745A (en) 2001-09-28
NO993684D0 (no) 1999-07-29
AU744907B2 (en) 2002-03-07
JP2001511143A (ja) 2001-08-07
KR20000070542A (ko) 2000-11-25
WO1998033811A1 (fr) 1998-08-06
PL334877A1 (en) 2000-03-27
AU5889298A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
US11000566B2 (en) Compositions and methods for modulating the immune system
TWI353848B (en) Mimotope peptide,composition,and immunogenic compo
KR100225679B1 (ko) 노나펩티드 봄베신 길항제
EP1438061B1 (fr) Copolymeres destines a la suppression de maladies auto-immunes, et methodes d'utilisation
IE912701A1 (en) Novel immunosuppressant peptides
KR20010041238A (ko) 인슐린의 펩티드 동족체를 사용하는 당뇨병의 치료 방법
CA2355400A1 (fr) Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de lareaction de l'hote contre le greffon (hvgd)
AU2002362445A1 (en) Copolymers for suppression of autoimmune diseases, and methods of use
CA2203629A1 (fr) Compositions et traitement pour la sclerose en plaques
WO1996012737A9 (fr) Compositions et traitement pour la sclerose en plaques
JP2607751B2 (ja) 自己免疫性ブドウ膜網膜炎の治療予防薬
JPH10501791A (ja) クラスｉｍｈｃペプチドによる細胞傷害性ｔ細胞リンパ球（「ｃｔｌ」）活性の調節
US9662370B2 (en) Peptidyl diacylglycerides
JP2007534621A (ja) Ｚｏｔおよびゾニューリンに対するレセプターのアゴニストペプチド
SK102199A3 (en) Peptides comprising a t-cell epitope specific to collagen ii, their use and pharmaceutical compositions containing such peptides
AU2005221187B2 (en) Method for inhibiting immune complex formation in a subjetc
US20020187934A1 (en) Peptide derivatives
JP4065322B2 (ja) 合成ペプチドおよびそれらを含有する医薬組成物
JP4160505B2 (ja) 自己免疫疾患の治療の構想における翻訳後型修飾を含むペプチドの使用
CZ269199A3 (cs) Peptidy obsahující T-buněčný epitop specifický pro kolagen, jejich použití a farmaceutické přípravky obsahující takové peptidy
AU3142102A (en) Peptides comprising a T-cell epitope specific to collagen II
JP2002521387A (ja) 共重合体１および関連する共重合体ならびにペプチドによる自己免疫疾患の治療